Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic and Functional Imaging in Pulmonary Hypertension with Ranolazine
NCT01917136Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in pulmonary hypertension (PH), sponsored by University of Pennsylvania. Started Aug 2013; status: completed.
02
Drugs
ranolazine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01917136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917136.